How Emergent BioSolutions Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile
The shortage of lifesaving medical equipment last year was a searing example of the government ’s failed coronavirus response. As health workers resorted to wearing trash bags, one Maryland company profited by selling anthrax vaccines to the country’s emergency reserve.
Source: NYT Health - Category: Consumer Health News Authors: Chris Hamby and Sheryl Gay Stolberg Tags: Coronavirus (2019-nCoV) Shortages Protective Clothing and Gear Anthrax Stockpiling Biological and Chemical Warfare Terrorism Drugs (Pharmaceuticals) Emergent BioSolutions Inc Biomedical Advanced Research and Development Authority Brigh Source Type: news
More News: Anthrax | Anthrax Vaccine | Chemistry | Coronavirus | COVID-19 | Emergency Medicine | Government | Health | Medical Devices | Vaccines